Latest news
Soriot should explain the curious case of AstraZeneca’s non-deal - The GuardianThe Guardian · Thu, 06 Aug 2026 01:30:00 GMTTuesday papers: AstraZeneca shares fall on Bristol Myers Squibb merger talks - CitywireCitywire · Wed, 05 Aug 2026 05:15:00 GMTAstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger - The GuardianThe Guardian · Mon, 03 Aug 2026 18:49:00 GMTAstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus - inklinkl · Mon, 03 Aug 2026 17:13:39 GMTAstraZeneca ‘in talks to create £300bn pharmaceutical giant’ - inklinkl · Mon, 03 Aug 2026 08:36:32 GMTAstraZeneca share prices drop amid £300bn mega-merger talks with US rival - inklinkl · Mon, 03 Aug 2026 07:14:54 GMTAstraZeneca falls to third-largest UK company amid US merger talks - The GuardianThe Guardian · Mon, 03 Aug 2026 07:05:00 GMT